
On 18 November 2026 TARPSWG held its Semi-annual Meeting in Seoul as part of the CTOS 2026 Annual Meeting. More than 130 members and guests took part, 117 in person and 19 online.
We thank CTOS for hosting us, and our local host Dr Kyo Won Lee and the Samsung Medical Center for their warm hospitality!
The programme covered the group’s main clinical, translational and registry activities:
- New trial concepts. STRASS 3 was discussed after the long-term STRASS results and the TRASTS experience. It came with translational projects on the sarcoma immune classification (SIC) and ctDNA. The group also discussed a randomised trial of an adjuvant CDK4/6 inhibitor after resection of a first recurrence of dedifferentiated liposarcoma.
- Ongoing trials. Updates were given on STRASS 2 / STREXIT 2, which is approaching its accrual target, and on the RELAPSE study.
- RESAR. The registry now includes more than 4,500 patients from 45 active centres. A simplified data dictionary goes live in December 2026. New studies on RESAR dataset are going to be launched.
- Global reach. A session focused on expanding RESAR in Asia, and the RPS resectability survey report was presented.
- Other projects. Updates were given on the ERAS guideline for RPS surgery, the Education Committee programme for 2027 and the Delphi consensus on terminology and operative standards in RPS surgery.
Save the date: our next Semi-annual Meeting will be on Wednesday 17 March 2027 in Washington, DC, the day before the SSO 2027 Annual Meeting. The meeting will also mark the 10th anniversary of RESAR.
Not yet a member? Join TARPSWG here: https://forms.gle/aGWZpyxt31BrjSGdA
